Company / Return on Equity (ROE)
Thermo Fisher Scientific Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
12.6%
FY2025
5-year range
9.1% / 16.5%
FY2021-FY2025
Trend
-1.8%
vs FY2024
Sector context
#36 of 148
Health Care
What the data says
Thermo Fisher Scientific's return on equity (roe) of 12.6% is higher than 76% of companies in the Health Care sector (FY2025). Return on Equity (ROE) has fluctuated over the past 7 years, ranging from 9.1% in FY2021 to 18.5% in FY2020.
Based on SEC 10-K filings.
12.6% in FY2025 with a 5-year CAGR of -5.9%. Top quartile in the Health Care sector.
Declined from 16.5% to 12.6% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -1.9pp
- 5-Year Change
- -5.9pp
- 10-Year Change
- -
Sector benchmark
Top 24% in Health CareTop 24% of 148This company 12.6% Sector average -3.2%
▼
+487.4% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 1.8% year-over-year.
- Currently 15.8pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2021.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.6% | -1.8% |
| FY2024 | 12.8% | -22.7% |
| FY2023 | 16.5% | +14.1% |
| FY2022 | 14.5% | +59.9% |
| FY2021 | 9.1% | -50.9% |
| FY2020 | 18.5% | +48.3% |
| FY2019 | 12.5% | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026